Table I.
Cytological and pathological results in the drug and control subgroups of the non-LEEP group.
| Subgroups | Subgroups | ||||
|---|---|---|---|---|---|
| Cytological results | Control | Drug | Pathological results | Control | Drug |
| ASC (n=92) | 51 | 41 | Chronic cervicitis (n=52) | 26 | 26 |
| HSIL (n=3) | 2 | 1 | Condyloma-like changes with chronic cervicitis (n=60) | 30 | 30 |
| LSIL (n=76) | 40 | 36 | Condyloma-like changes (n=52) | 26 | 26 |
| NILM (n=68) | 37 | 31 | CIN 1 with condylomalike changes (n=26) | 13 | 13 |
| Total (n=266) | 148 | 118 | CIN 1 and CIN 1–2 (n=14) | 7 | 7 |
| CIN 2 (n=14) | 7 | 7 | |||
| Total (n=218) | 109 | 109 | |||
LEEP, loop electrosurgical excision procedure; ASC, atypical squamous cells; HSIL, highgrade squamous intraepithelial lesion; LSIL, lowgrade squamous intraepithelial lesion; NILM, negative for intraepithelial lesion and malignancy; CIN, cervical intraepithelial neoplasia.